Clinical
Follow pivotal data releases and trial developments that create new strategic pressure for biotech and pharma operators.
70 signals
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.
CLINICAL
This study evaluates the impact of an educational intervention on sexual function and treatment adherence in women with breast cancer.
CLINICAL
A rollover study has been initiated to provide continued access to dabrafenib and/or trametinib for patients benefiting from these treatments.
CLINICAL
The RESYNC-PETCT study aims to improve CRT response in heart failure patients with non-LBBB or narrow LBBB patterns through advanced imaging guidance.
CLINICAL
The study evaluates the implementation of the ACS GSV Program at James Cancer Hospital to enhance surgical outcomes for older adults.
CLINICAL
The CANUT Junior study is assessing sensory changes in pediatric oncology patients, with initial recruitment challenges leading to protocol amendments.
CLINICAL
The ROBIN trial will investigate the molecular effects of standard short course radiotherapy on rectal cancer and its impact on the immune system.
CLINICAL
A new early rehabilitation protocol, EMOVE-BCS-LaFe, is being evaluated for safety and feasibility in breast cancer surgery patients.
CLINICAL
The NORM-HF study aims to show that the FIRE1 NORM™ System is superior to standard care in managing heart failure.
CLINICAL
A clinical trial is evaluating the combination of durvalumab, bevacizumab, and TACE for advanced HCC, focusing on 6-month progression-free survival.
CLINICAL
A study is underway to evaluate nemtabrutinib against ibrutinib or acalabrutinib in treatment-naive CLL/SLL patients.
CLINICAL
A randomized trial is assessing whether S-ICD implantation without defibrillation testing is non-inferior to the standard method.
CLINICAL
A clinical trial is assessing the safety and feasibility of R-MVST cells for patients with refractory viral infections caused by EBV, CMV, ADV, or BK virus.
CLINICAL
STARD10 is implicated in the progression of HER2+ breast cancer and regulates intracellular lipid metabolism via the cAMP/PKA/CREB1 signaling pathway.
CLINICAL
The OTAC trial is assessing the safety and efficacy of hIVIG versus placebo in outpatients with COVID-19.
CLINICAL
A clinical trial is evaluating the effectiveness of posterosuperior bundle pacing in reducing atrial fibrillation incidence in patients with sinus node dysfunction.
COMPETITIVE
Boomerang Medical is conducting a pivotal trial to evaluate a device aimed at reducing bowel urgency in ulcerative colitis patients.
CLINICAL
A clinical trial is underway to evaluate DB-1303/BNT323 against investigator's choice chemotherapy in HER2-low, HR+ metastatic breast cancer.
CLINICAL
A clinical trial is assessing the effects of a structured exercise program on quality of life and health outcomes in prostate cancer patients.
CLINICAL
A multi-center, retrospective study will analyze real-world data from 3,500 patients with breast phyllodes tumors in China.
CLINICAL
The trial aims to establish the pharmacokinetic equivalence, safety, and immunogenicity of KSHB002 compared to ORENCIA in healthy subjects.
CLINICAL
Polyploid giant cancer cells (PGCCs) contribute to therapy resistance and poor prognosis in ovarian cancer.
CLINICAL
A novel lactylation-related prognostic model (CM-LP11) effectively stratifies cutaneous melanoma patients into high- and low-risk groups based on overall survival.
CLINICAL
Gut bacteria metabolize Flutamide into inactive forms, reducing its therapeutic efficacy against prostate cancer.
CLINICAL
The study identifies age, neoadjuvant therapy, and tumor characteristics as risk factors for second primary cancer in colorectal cancer survivors.
CLINICAL
Amplification of ARHGAP29 and SLC44A3 genes adjacent to F3 is associated with worse overall and disease-free survival in pancreatic adenocarcinoma.
Showing 1–25 of 70 records